Fasano and team work to expand and refine screening for newborn immune disorder

Though symptomless at birth, infants with severe combined immunodeficiency disorder (SCID) are at high risk for developing infections that they are unable to fight off, often leading to death before the age of two. Fortunately, the genetic disorder is treatable by hematopoietic stem cell transplantation if it is diagnosed early enough, and Dr. Mary Beth […]